BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Realizing a new paradigm in human genetics guided drug discovery -
  Dr Nadeem Sarwar - President Eisai AiM
DTSTART:20170524T160000Z
DTEND:20170524T170000Z
UID:TALK72623@talks.cam.ac.uk
CONTACT:Sylvie Robinson
DESCRIPTION:Nadeem’s expertise stems from the intersection of innovation
  in human genetics and data sciences with collaborative business models to
  accelerate delivery of novel\, targeted therapeutics. He is Founder and P
 resident of the Eisai AiM Institute\, an industry unique discovery innovat
 ion unit exclusively focused on realizing human genetics guided drug disco
 very and precision medicine. He has senior-level experience within academi
 a (tenured faculty\, University of Cambridge)\, big-pharma (Senior Directo
 r\, Pfizer)\, medium-sized pharma (Vice President\, Eisai)\, and Biotech-l
 ike organizations (President\, Eisai AiM Institute). \nNadeem’s research
  has been published in leading medical journals (eg\, NEJM\, Lancet\, JAMA
 )\, presented at international meetings (eg\, American Diabetes Associatio
 n\, Prix Galien Foundation\, Hitachi Innovation)\, and profiled by interna
 tional media (eg\, BBC\, Forbes\, Nature). He has been invited to provide 
 expert insights on human genetics and drug discovery for The World Dementi
 a Envoy\, Genomics England\, The UK Minster for Life Sciences and Scottish
  Enterprise. \nNadeem has served as Chair of: The US National Academies Wo
 rkshop on “Drug Discovery From Genetic Bioresources”\; The World CNS S
 ummit\; The Drug Discovery Stream of the Festival of Genomics\; and The Ex
 ternal Advisory Board of the NIA Longevity Genomics Study. In addition\, h
 e serves as industry lead for the ADNI Genetics Core\; sits on the US Inst
 itute of Medicine Roundtable on Genomics & Precision Health\; and facilita
 tes the Industry Partnership for Human Genetics.\nPrior to working in the 
 pharmaceutical industry\, Nadeem was tenured faculty at the School of Clin
 ical Medicine\, University of Cambridge (UK)\, where he was involved in le
 ading large-scale research consortia and new bioresources focused on ident
 ifying causal and predictive disease risk factors. He served as Principal 
 Investigator of the IL6R Genetics Consortium and the Triglycerides & Coron
 ary Disease Genetics Consortium\; and Steering Committee & Leadership Team
  member of the Emerging Risk Factors Collaboration\, the Pakistan Risk of 
 Myocardial Infarction Study and Generation Scotland. He trained in genetic
  and molecular epidemiology with Professor John Danesh (University of Camb
 ridge\, UK).\n
LOCATION:CRUK Cambridge Research Institute Lecture Theatre (Li Ka Shing Ce
 ntre - Robinson Way)
END:VEVENT
END:VCALENDAR